
Preview Health is a company pioneering AI-powered molecular profiling for precision medicine. They aim to revolutionize biomarker analysis in diagnostics and clinical trials to develop new biological tests and accelerate cures for currently incurable diseases. Their technology analyzes metabolites, the smallest molecules in the body, to gain real-time insights into a person's health. By using cutting-edge AI to interpret complex data patterns from biological samples, they create unique molecular fingerprints for personalized health insights. The company's mission is to transform diagnosis with precision, accelerate and optimize clinical trials, and deliver breakthrough treatments by enabling earlier and more accurate disease detection and the development of targeted therapies.

Preview Health is a company pioneering AI-powered molecular profiling for precision medicine. They aim to revolutionize biomarker analysis in diagnostics and clinical trials to develop new biological tests and accelerate cures for currently incurable diseases. Their technology analyzes metabolites, the smallest molecules in the body, to gain real-time insights into a person's health. By using cutting-edge AI to interpret complex data patterns from biological samples, they create unique molecular fingerprints for personalized health insights. The company's mission is to transform diagnosis with precision, accelerate and optimize clinical trials, and deliver breakthrough treatments by enabling earlier and more accurate disease detection and the development of targeted therapies.
Founded: 2023
Headquarters: Sydney, Australia
Focus: AI-powered metabolomic diagnostics for early brain health (Parkinson's emphasis)
Stage: Pre-Seed / early-stage
Founders: Dr. Diana Zhang; Anastasia Latin
Early detection and precision diagnostics for neurodegenerative / brain health conditions (initial emphasis on Parkinson's disease).
2023
Biotechnology
Pre-Seed round listed with amounts obfuscated/undisclosed.
“UNSW Founders (listed as investor in company snapshot)”